Ardent Health director granted 14,231 ARDT shares

BYNOE PETER C B reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

BYNOE PETER C B reported acquisition or exercise transactions in this Form 4 filing.

Ardent Health, Inc. director Peter C. B. Bynoe reported an equity award of 14,231 shares of Common Stock, received as a grant at no cash cost per share. These are restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to his continued service. Following this award, he holds 115,367 shares directly.

Insider Trade Summary

Grant/Award: 14,231 shares

Grant/Award 1 txn

Insider BYNOE PETER C B

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,231	$0.00	$0.00

Holdings After Transaction: Common Stock — 115,367 shares (Direct)

Footnotes (1)

1. F1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Key Figures

Equity grant size: 14,231 shares Post-transaction holdings: 115,367 shares Grant price per share: $0.0000 per share

3 metrics

Equity grant size 14,231 shares Restricted stock units granted on April 1, 2026

Post-transaction holdings 115,367 shares Total Common Stock directly held after grant

Grant price per share $0.0000 per share Compensation-related award, not a market purchase

Key Terms

restricted stock units, vest in full, Grant, award, or other acquisition

3 terms

restricted stock units financial

"Represents restricted stock units that vest in full on the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest in full financial

"restricted stock units that vest in full on the first anniversary"

Grant, award, or other acquisition financial

"transaction_code_description":"Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ARDT director Peter Bynoe report?

Director Peter C. B. Bynoe reported receiving 14,231 shares of Ardent Health Common Stock as an equity grant. The award was recorded as a grant or award acquisition rather than an open-market purchase or sale, reflecting compensation rather than trading activity.

How many Ardent Health (ARDT) shares does Peter Bynoe hold after this grant?

After the reported grant, Peter C. B. Bynoe holds 115,367 shares of Ardent Health Common Stock directly. This figure includes the newly awarded 14,231 restricted stock units, giving investors a sense of his total reported stake following the transaction.

What are the vesting terms of Peter Bynoe’s ARDT restricted stock units?

The 14,231 restricted stock units vest in full on the first anniversary of April 1, 2026, if Peter C. B. Bynoe continues serving Ardent Health through that date. Vesting conditions mean he must remain in service for the award to fully settle in shares.

Was Peter Bynoe’s ARDT transaction a market buy or sell?

The transaction was not a market buy or sell. It is coded as a grant, award, or other acquisition of 14,231 shares at a transaction price of $0.0000 per share, indicating a compensation-related equity award rather than an open-market trade.

Does the ARDT Form 4 indicate any derivative exercises by Peter Bynoe?

The Form 4 data show no derivative transactions or option exercises for Peter C. B. Bynoe in this report. The filing only reflects a non-derivative equity grant of Common Stock, with no remaining derivative positions listed in the derivative summary.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 04:48 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BYNOE PETER C B

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		14,231(1)	A	$0	115,367	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)